New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes

Stock Information for Genetic Technologies Ltd

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Genetic Technologies Ltd

Appendix 4C & Quarterly Business Update - March 2024
Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering
Genetic Technologies Announces $2 Million Registered Direct Offering
GeneType Clinicians' Adoption Growing - Sales up 5-Fold Year on Year
Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
GTG to pilot GeneType in Breast Screen centers across the U.S.
EVENT - Empowering Women Through Knowledge; Humanise Health & GeneType Launch "Know Your Risk"
Genetic Technologies' Digital Strategy Ignites Significant Traction in US Market

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.